Arrhythmias in the coronary-care unit. VI. Physiologic bases for the use of antiarrhythmic drugs.
Classification of antiarrhythmic drugs based on their electrophysiologic and hemodynamic properties coupled with an understanding of the transmembrane action potential of the cardiac cell (see the first of this series of six vignettes) help in the appropriate choice of therapy in a given clinical setting.
D006321:Heart / Q000187:drug effects; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D011802:Quinidine / Q000494:pharmacology / Q000627:therapeutic use*; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy* / Q000209:etiology
D008012:Lidocaine; D011802:Quinidine